Published in Exp Ther Med on October 18, 2016
Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest (2006) 3.45
Mesenchymal stem cells. Exp Biol Med (Maywood) (2001) 2.80
Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int (1982) 2.80
Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med (2009) 2.51
Cellular and molecular mechanisms of bone remodeling. J Biol Chem (2010) 2.39
Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci (2009) 2.35
Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A (2008) 1.97
PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol (2010) 1.72
Type 2 diabetes and bone. J Bone Miner Res (2012) 1.53
Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB. J Bone Miner Res (2007) 1.42
Local anaesthetic activity of beta-caryophyllene. Farmaco (2001) 1.28
Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol (2011) 1.26
Obesity and fracture in men and women: an epidemiologic perspective. J Bone Miner Res (2012) 1.24
Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res (2011) 1.19
Analgesic and anti-inflammatory activity of Caryophyllene oxide from Annona squamosa L. bark. Phytomedicine (2009) 1.12
A high-fat diet increases IL-1, IL-6, and TNF-α production by increasing NF-κB and attenuating PPAR-γ expression in bone marrow mesenchymal stem cells. Inflammation (2013) 1.11
Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J Bone Miner Res (2003) 1.02
Adverse effects of hyperlipidemia on bone regeneration and strength. J Bone Miner Res (2012) 1.01
How are osteoclasts induced to resorb bone? Ann N Y Acad Sci (2011) 0.93
Production and diversity of volatile terpenes from plants on calcareous and siliceous soils: effect of soil nutrients. J Chem Ecol (2008) 0.93
Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception. Eur J Pain (2012) 0.88
Exogenous regucalcin suppresses osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture. Integr Biol (Camb) (2012) 0.83
Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis. Cell Tissue Res (2014) 0.83
Tephrosia sinapou ethyl acetate extract inhibits inflammatory pain in mice: opioid receptor dependent inhibition of TNFα and IL-1β production. Pharm Biol (2013) 0.81
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine (2013) 0.80
Regulatory role of regucalcin in heart calcium signaling: Insight into cardiac failure (Review). Biomed Rep (2014) 0.80
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro. Int J Mol Med (2016) 0.75
Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro. Exp Ther Med (2017) 0.75
Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Mol Med Rep (2015) 0.75
The potential role of regucalcin in kidney cell regulation: Involvement in renal failure (Review). Int J Mol Med (2015) 0.75